Cargando…
DLC1: a tumor suppressor that regulates Rho signaling
Autores principales: | Tripathi, Brajendra K., Lowy, Douglas R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5438599/ https://www.ncbi.nlm.nih.gov/pubmed/28402946 http://dx.doi.org/10.18632/oncotarget.16805 |
Ejemplares similares
-
SRC and ERK cooperatively phosphorylate DLC1 and attenuate its Rho-GAP and tumor suppressor functions
por: Tripathi, Brajendra K., et al.
Publicado: (2019) -
CDK5 is a major regulator of the tumor suppressor DLC1
por: Tripathi, Brajendra K., et al.
Publicado: (2014) -
DLC-1:a Rho GTPase-activating protein and tumour suppressor
por: Durkin, Marian E, et al.
Publicado: (2007) -
Receptor tyrosine kinase activation of RhoA is mediated by AKT phosphorylation of DLC1
por: Tripathi, Brajendra K., et al.
Publicado: (2017) -
Inhibition of cytoplasmic EZH2 induces antitumor activity through stabilization of the DLC1 tumor suppressor protein
por: Tripathi, Brajendra K., et al.
Publicado: (2021)